Private Equity
Core Equity Holdings’ Thomas de Waen, Campbell Lutyens’ Sarah Sandstrom and Glendower Capital’s Carlo Pirzio-Biroli share what matters most for spin-out success.
1 min read · 18 February 2021
The pandemic might have had a beneficial effect on fundraising by “highlighting how impactful healthcare innovation can be,” Sagard's David MacNaughtan told Buyouts.
3 min read · 18 February 2021
PEI caught up with Tony Morgan, head of private equity and corporate debt at CDC Group, to discuss the firm’s expansion into South Asian and African venture capital.
2 min read · 18 February 2021
The pension system has been steadily growing its co-investment and secondaries program over the last year, and plans to do more in the future.
2 min read · 17 February 2021
2021 marks the year products aimed at tapping the defined contribution market see the light of day. Increased interest in such vehicles suggests more are soon to come.
3 min read · 17 February 2021
We catch up with chairman Denis Ribon, whose firm raised €1bn for its largest healthcare fund last year, to discuss the firm’s US expansion and competition in the mid-market.
3 min read · 17 February 2021
A group of Democrats is pushing for carried interest reform in the US. Plus: Why not all of Dyal's portfolio GPs might be happy about its Owl Rock tie-up; and how NAV facilities transitioned from niche to mainstream. Here's today's brief, for our valued subscribers only.
4 min read · 17 February 2021
Fund VI was “very significantly oversubscribed,” president and CEO Pascal Tremblay told Buyouts, with Novacap “more than doubling” the size of its investor base.
4 min read · 17 February 2021
Critics of private equity have long considered this a loophole that allows already-wealthy private equity GPs to pay less than regular workers.
2 min read · 17 February 2021
The firm said its focus on 'targeted transactions' as opposed to buying large LP portfolios will work to its advantage in the current market.
2 min read · 16 February 2021
